KURAMOCHI BOUNDARIES OF RIEMANN SURFACES.

Por MAEDA F Y., OHTSUKA M.
Publicado em C1968

Cell signaling during Trypanosoma cruzi invasion

Por Maeda, Fernando Y., Cortez, Cristian, Yoshida, Nobuko
Publicado em 2012

Prática pneumológica : 101 casos selecionados do dia-a-dia /

Por Maeda, T. Y., Noronha Filho, A. J., Lopes, A. J.
Publicado em 1998.

Snap-to-it probes: chelate-constrained nucleobase oligomers with enhanced binding specificity

Por Morgan, Joel R., Lyon, Robert P., Maeda, Dean Y., Zebala, John A.
Publicado em 2008

Nicotinamide Glycolates Antagonize CXCR2 Activity through an Intracellular Mechanism

Por Maeda, Dean Y., Quinn, Mark T., Schepetkin, Igor A., Kirpotina, Liliya N., Zebala, John A.
Publicado em 2010

Factors influencing outcomes in patients with Eisenmenger syndrome: a nine-year follow-up study

Por Clavé, Mariana M., Maeda, Nair Y., Castro, Claudia R. P., Bydlowski, Sergio P., Lopes, Antonio A.
Publicado no Pulm Circ (2017)

Co-infection with Trypanosoma cruzi protects mice against early death by neurological or pulmonary disorders induced by Plasmodium berghei ANKA

Por Egima, Claudia M, Macedo, Silene F, Sasso, Gisela RS, Covarrubias, Charles, Cortez, Mauro, Maeda, Fernando Y, Costa, Fabio T, Yoshida, Nobuko
Publicado em 2007

A MFS-like plasma membrane transporter required for Leishmania virulence protects the parasites from iron toxicity

Por Laranjeira-Silva, Maria Fernanda, Wang, Wanpeng, Samuel, Tamika K., Maeda, Fernando Y., Michailowsky, Vladimir, Hamza, Iqbal, Liu, Zhongchi, Andrews, Norma W.
Publicado no PLoS Pathog (2018)

Relation of Macrophage Migration Inhibitory Factor to Pulmonary Hemodynamics and Vascular Structure and Carbamyl-Phosphate Synthetase I Genetic Variations in Pediatric Patients wit...

Por Maeda, Nair Y., Aiello, Vera D., Santos, Paulo C., Thomaz, Ana M., Kajita, Luiz J., Bydlowski, Sérgio P., Lopes, Antonio Augusto
Publicado no Mediators Inflamm (2019)

Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2

Por Maeda, Dean Y., Peck, Angela M., Schuler, Aaron D., Quinn, Mark T., Kirpotina, Liliya N., Wicomb, Winston N., Fan, Guo-Huang, Zebala, John A.
Publicado em 2014

Boronic acid-containing CXCR1/2 antagonists: optimization of metabolic stability, in vivo evaluation, and a proposed receptor binding model

Por Maeda, Dean Y., Peck, Angela M., Schuler, Aaron D., Quinn, Mark T., Kirpotina, Liliya N., Wicomb, Winston N., Auten, Richard L., Gundla, Rambabu, Zebala, John A.
Publicado no Bioorg Med Chem Lett (2015)

Boronic Acid-Containing Aminopyridine- and Aminopyrimidinecarboxamide CXCR1/2 Antagonists: Optimization of Aqueous Solubility and Oral Bioavailability

Por Schuler, Aaron D., Engles, Courtney A., Maeda, Dean Y., Quinn, Mark T., Kirpotina, Liliya N., Wicomb, Winston N., Mason, S. Nicholas, Auten, Richard L., Zebala, John A.
Publicado no Bioorg Med Chem Lett (2015)

Intestinal Transport of Aminopterin Enantiomers in Dogs and Humans with Psoriasis Is Stereoselective: Evidence for a Mechanism Involving the Proton-Coupled Folate Transporter

Por Menter, Alan, Thrash, Breck, Cherian, Christina, Matherly, Larry H., Wang, Lei, Gangjee, Aleem, Morgan, Joel R., Maeda, Dean Y., Schuler, Aaron D., Kahn, Stuart J., Zebala, John A.
Publicado em 2012

IL-8 signaling does not mediate intra-amniotic LPS-induced inflammation and maturation in preterm fetal lamb lung

Por Kallapur, Suhas G., Moss, Timothy J. M., Auten, Richard L., Nitsos, Ilias, Pillow, J. Jane, Kramer, Boris W., Maeda, Dean Y., Newnham, John P., Ikegami, Machiko, Jobe, Alan H.
Publicado em 2009

Effective Combinatorial Immunotherapy for Castration Resistant Prostate Cancer

Por Lu, Xin, Horner, James W., Paul, Erin, Shang, Xiaoying, Troncoso, Patricia, Deng, Pingna, Jiang, Shan, Chang, Qing, Spring, Denise J., Sharma, Padmanee, Zebala, John A., Maeda, Dean Y., Wang, Y. Alan, DePinho, Ronald A.
Publicado no Nature (2017)

Dengue Virus Type 4 Phylogenetics in Brazil 2011: Looking beyond the Veil

Por de Souza, Renato Pereira, Rocco, Iray M., Maeda, Adriana Y., Spenassatto, Carine, Bisordi, Ivani, Suzuki, Akemi, Silveira, Vivian R., Silva, Sarai J. S., Azevedo, Roberta M., Tolentino, Fernanda M., Assis, Jaqueline C., Bassi, Margarida G., Dambrós, Bibiana P., Tumioto, Gabriela L., Gregianini, Tatiana S., Souza, Luiza Terezinha M., Timenetsky, Maria do Carmo S. T., Santos, Cecília L. S.
Publicado em 2011

KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer

Por Liao, Wenting, Overman, Michael J., Boutin, Adam T., Shang, Xiaoying, Zhao, Di, Dey, Prasenjit, Li, Jiexi, Wang, Guocan, Lan, Zhengdao, Li, Jun, Tang, Ming, Jiang, Shan, Ma, Xingdi, Chen, Peiwen, Katkhuda, Riham, Korphaisarn, Krittiya, Chakravarti, Deepavali, Chang, Andrew, Spring, Denise J., Chang, Qing, Zhang, Jianhua, Maru, Dipen M., Maeda, Dean Y., Zebala, John A., Kopetz, Scott, Alan Wang, Y., DePinho, Ronald A.
Publicado no Cancer Cell (2019)